Oracles, Billion

Oracle's $23.7 Billion Cash Drain Undermines a $638 Billion Backlog

Published on 07/05/2026 at 16:32 | Redaktion boerse-global.de

Oracle's stock plunges 36% despite $638B backlog, driven by OpenAI dependency, massive capex, and a $23.7B free cash flow deficit.

Oracle's $638B Backlog vs. Stock Drop: AI Deal Risks and Cash Burn
Oracle's $23.7 Billion Cash Drain Undermines a $638 Billion Backlog Illustration mit AI erstellt ĂĽbermittelt durch boerse-global.de

Oracle finds itself in a peculiar bind: a contract pipeline worth more than the entire company, yet a stock that has shed over a third of its value in a single month. The disconnect between its record $638 billion in remaining performance obligations and a deteriorating cash position has rattled investors far more than the headline numbers suggest.

Shares closed at €126.30 on Friday, gaining 2.83% on the day, but that small bounce does little to mask a brutal 30-day slide of 36.45%. Year-to-date, the stock is down 24.37%, and over twelve months it has tumbled 37.49%. At a market capitalisation of roughly €353 billion, Oracle is now valued at barely half its backlog—an unusual inversion for a company that once traded as a steady software stalwart.

The OpenAI dependency and the credit cloud

The bulk of that backlog comes from a single five-year contract with OpenAI valued at over $300 billion, due to start in 2027. On paper, the deal positions Oracle as a critical infrastructure provider for the AI boom. In practice, it concentrates risk. Oracle recently warned in regulatory filings about the possibility of customer payment defaults. That warning lands hard given OpenAI’s own financial struggles: audited losses for 2025 reached $38.5 billion. The health of the company’s biggest tenant is a growing source of anxiety.

Analysts have begun to label this a “Klumpenrisiko” — a cluster risk that could turn a blockbuster order book into a liability if the end user falters. The broader market is already repricing the stock for that scenario.

Should investors sell immediately? Or is it worth buying Oracle?

Spending now, hoping for later

To fulfil those commitments, Oracle is spending aggressively. For fiscal 2026, capital expenditure is budgeted at $55.7 billion, overwhelmingly directed at data centres and GPU clusters. The consequence: a projected free cash flow deficit of $23.7 billion, up from a mere $394 million shortfall the prior year. The pace of cash burn has escalated so quickly that Oracle plans to raise $40 billion through bonds and new equity.

The secondary article adds that by fiscal 2027, capex is expected to hit $95 billion, further straining a balance sheet already carrying over $100 billion in debt. Meanwhile, competitors like Microsoft sit on enormous cash piles; Oracle is funding its expansion on credit and equity dilution.

The company is also restructuring. Reports from early July 2026 indicate thousands of layoffs, predominantly among experienced engineers and architects, with savings redirected to Oracle’s cloud infrastructure OCI and GPU clusters. The message is clear: the old Oracle is being dismantled to make way for a capital-intensive AI builder.

Technicals and macro headwinds

On a purely technical basis, the stock looks deeply oversold. The 14-day relative strength index sits at 30.4, a level that often triggers contrarian interest. The current price is just 10.93% above the 52-week low of €113.86 set on 6 February 2026, and 55.01% below the record high of €280.70 from September 2025. The gap to the 50-day moving average is 21.30%; to the 200-day, 25.41%. Annualised volatility stands at 71.47%.

Yet the macro environment is adding pressure. June US employment data showed only 57,000 new jobs, keeping interest rates elevated and punishing capital-intensive companies like Oracle. Investors are rotating out of AI-exposed names into defensive consumer staples, exacerbating the selloff.

Oracle at a turning point? This analysis reveals what investors need to know now.

Analysts remain optimistic on a price target basis: the consensus target is €221.03, implying roughly 75% upside from current levels. But bridging that gap requires more than hope. It demands that the colossal backlog converts into high-margin revenue before the cash deficit becomes unmanageable. With an ex-dividend date of 10 July 2026 (paying $0.50 per share), income-oriented holders have a near-term date to watch, but the dividend is incidental to the larger story.

Oracle is trapped between a historic order book and a punishing investment cycle. The market’s message is blunt: without proof that the spending will generate sustainable profits soon, a full order book means little when the cash register is empty.

Ad

Oracle Stock: New Analysis - 5 July

Fresh Oracle information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Oracle analysis...

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | US68389X1054 | ORACLES | boerse | 69697813 |